You can earn 1 CE credit by viewing this FREE online course. All details about the webinar have been included below. To get started, click here to sign up. The presentation will begin directly after.
Webinar Overview
In this webinar, the opioid crisis will be discussed, including statements and guidelines from the American Dental Association (ADA). Centers for Disease Control and Prevention (CDC) guidelines for prescribing medications, as well as overdose statistics from the National Institute on Drug Abuse will also be presented. In addition, there will be a review of statistics of the Prescription Drug Monitoring Program (PDMP).
Objectives
Upon completion of the course, the participant will have knowledge of:
- CDC Guidelines for prescribing
- Statistics of Overdose
- Statistics of PDMP including individual states
- Resources for more information
Presenter
James Grant, DDS
Dr. James Grant currently works at DentaQuest as Dental Director for Colorado and is the owner of Grant Dental Technology Corporation, a company that designs, develops and produces dental implant and associated surgical and restorative instruments. Previously, he had a private practice in Colorado Springs for 22 years. He has lectured and consulted for many dental organizations and has written articles for publications.
Ready to begin the online course? Click here to sign up and the presentation will begin directly after.
Contact susan.bitler@nationaldentex.com with any questions.
National Dentex is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
National Dentex designates this activity for 1 continuing education credit.
 |
National Dentex
Nationally Approved PACE Program
Provider for FAGD/MAGD credit.
Approval does not imply acceptance by
any regulatory authority or AGD endorsement.
10/1/2017 to 9/30/2021
Provider ID# 211838 |
Original release date: 08/06/2018